Home Financial Results

Financial Results

Following a solid third quarter, LANXESS confirms its earnings forecast for 2018

Sales increased by 4.4 percent to EUR 1.79 billion in the third quarter EBITDA pre exceptionals 1.5 percent higher at EUR 277 million EBITDA margin pre exceptionals at 15.5 percent Net income from continuing operations increased to EUR...

ICRA: Hospital sector continues to be under weather in Q2 FY2019

Operating margin drops from 15.0% in Q2 FY2018 to 13.3% In Q2 FY2019 Structurally, in the long term, underlying fundamentals continue to favour the sector The muted performance of the hospital sector continues in Q2 FY2019. The companies in...

Kilitch Drugs (India) records a robust growth in Q2FY19

Net Sales up (YoY) to Rs. 26.72 crore Registers a net profit of Rs.4.49 crore EPS for the second quarter stood at Rs. 3.20   BSE Code: 524500 NSE Code: KILITCH _______________________________  FY18 Sales: Rs. 58.94 crore FY18 EBIDTA: Rs. 6.41 crore _________________________________________  Headquartered in Mumbai (India),...

Cipla announces Q2 FY19 results

Mumbai, November 28, 2018: Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its unaudited consolidated financial results for quarter ended September 30, 2018. Key highlights of the quarter R&D investments at ~INR 316cr / ~8% of sales Continued growth momentum: Growth...

Apollo Hospitals announces Q2 & H1FY19 results

New Delhi, November 24, 2018: Launched the first-ever AI-powered Cardiovascular Disease Risk Score API (Application Program Interface), designed specifically to predict risk of Cardiovascular Disease in the Indian population Became the most awarded hospital group in Asia for the fifth successive...

Following a good second quarter, LANXESS specifies its earnings forecast for 2018

Full year 2018: Increase of EBITDA pre exceptionals now expected at the upper end of the guidance of five to ten percent against the previous year Group sales increased by 6.8 percent to around EUR 1.8 billion in...

Middle East and Africa pharma economy to reach US$38.8bn by 2021

CPhI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to further increase local manufacturing Amsterdam, August 15, 2018: CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are...

Morepen Labs begins FY 2018-19 with a Sound Performance in the First Quarter

Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue in Q1 of FY 2018-19 New Delhi, August 15, 2018: Highlights Q1 FY 2018-19 (Consolidated) Net Sales Revenue up by...

Apollo Hospitals announces Q1 FY19 results

New Delhi, August 12, 2018: Q1FY19 Standalone Revenues grew 16% to Rs.19,104 million compared to Rs.16,504 million in Q1FY18, aided by SAP growth of 20% and Healthcare services growth of 12% YoY. HC services growth of 12% YoY was...

Glenmark Pharma Q1 profit at ₹232.99 crore

New Delhi, August 12, 2018: Pharma major Glenmark Pharmaceuticals on Friday reported consolidated net profit of ₹232.99 crore in the first quarter ended 30 June 2018. The company had posted consolidated net profit of ₹333.38 crore in the same quarter...